Pathstone Holdings’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.98M | Sell |
6,076
-222
| -4% | -$72.4K | 0.01% | 1003 |
|
|
2025
Q1 | $1.7M | Buy |
6,298
+115
| +2% | +$31.1K | 0.01% | 1070 |
|
|
2024
Q4 | $1.45M | Sell |
6,183
-66
| -1% | -$15.5K | 0.01% | 1158 |
|
|
2024
Q3 | $1.72M | Buy |
6,249
+629
| +11% | +$173K | 0.01% | 1067 |
|
|
2024
Q2 | $1.37M | Buy |
5,620
+1,762
| +46% | +$428K | 0.01% | 1127 |
|
|
2024
Q1 | $577K | Buy |
3,858
+974
| +34% | +$146K | ﹤0.01% | 1610 |
|
|
2023
Q4 | $552K | Buy |
+2,884
| New | +$552K | ﹤0.01% | 1436 |
|